MYOSANA THERAPEUTICS
Myosana Therapeutics is a new biotech company developing novel platform technology for non-viral gene delivery. Myosana Therapeutics has developed a non-viral gene delivery platform technology that specifically targets muscle cells to produce the missing protein caused by a mutation of a gene.
MYOSANA THERAPEUTICS
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2018-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.myosanatherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
1.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network GStatic Google Static Content Wix
Similar Organizations
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Advisors List
Current Employees Featured
Founder
Investors List
Parent Project Muscular Dystrophy
Parent Project Muscular Dystrophy investment in Grant - Myosana Therapeutics
CureDuchenne Ventures
CureDuchenne Ventures investment in Seed Round - Myosana Therapeutics
Official Site Inspections
http://www.myosanatherapeutics.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Myosana Therapeutics"
Non Viral Gene Therapy Companies: Trailblazing Genetic Medicine
Jan 25, 2023 · Myosana is pioneering a targeted non-viral gene therapy platform for neuromuscular and cardiac genetic diseases. Our platform is designed to overcome the …See details»
Neuromuscular Disease Treatment: Myosana's …
At Myosana Therapeutics, patients are our enduring focus and motivation. Our mission is to develop new gene therapies that save lives, increase longevity, and improve quality of life for people with neuromuscular and cardiac genetic …See details»
Leadership - Myosana Therapeutics
Myosana Therapeutics, Inc. is leading the efforts in developing new gene therapies that will slow skeletal muscle degeneration and heart failure to improve the quality of life, increase longevity …See details»
Myosana Therapeutics, Inc - LinkedIn
Myosana Therapeutics, Inc. is pioneering efforts in developing non-viral targeted gene therapy for skeletal muscle and cardiac diseases. Our current focus is Duchenne muscular dystrophy (DMD)...See details»
Myosana Therapeutics - Crunchbase Company Profile & Funding
View contacts for Myosana Therapeutics to access new leads and connect with decision-makers. Myosana Therapeutics is a new biotech company developing novel platform technology for …See details»
Myosana Therapeutics, Inc. - News, Locations, Executives and ...
Usearch has identified 1 executive & key decision-maker. The company domain name is myosanatherapeutics.com.See details»
Myosana Therapeutics Raises $5 Million in Seed Funding
Jan 25, 2023 · SEATTLE-- ( BUSINESS WIRE )-- Myosana Therapeutics, Inc., pioneer of a muscle-specific non-viral gene therapy platform for neuromuscular and cardiac diseases, …See details»
Myosana Therapeutics Company Profile 2024: Valuation, Funding ...
Developer of non-viral new gene therapies designed to slow down skeletal muscle degeneration and heart failure.See details»
Our Science - Myosana Therapeutics
Myosana is pioneering a targeted non-viral gene therapy platform for neuromuscular and cardiac genetic diseases. Our platform is designed to overcome the limitations of viral delivery, …See details»
Myosana Therapeutics, Inc. Raises Up To $1M from CureDuchenne …
Apr 22, 2020 · Newport Beach, CA & Seattle, WA, April 22, 2020: Myosana Therapeutics, Inc., a new biotech company developing novel platform technology for non-viral gene delivery, raised …See details»
Parent Project Muscular Dystrophy Invests $350,480 in Myosana ...
Aug 26, 2021 · Myosana's technology, created by Co-Founders Nick Whitehead and Stan Froehner, aims to address the problems posed by AAV administration through their …See details»
Parent Project Muscular Dystrophy Invests $350,480 in Myosana ...
Aug 26, 2021 · Myosana's technology, created by Co-Founders Nick Whitehead and Stan Froehner, aims to address the problems posed by AAV administration through their …See details»
Myosana Therapeutics - Craft
Myosana Therapeutics is a biotech company developing a platform technology for non-viral gene delivery. Its platform technology specifically targets muscle cells to produce the missing …See details»
Myosana Therapeutics - VentureRadar
Website: http://www.myosanatherapeutics.com/ Develops gene therapies targeting skeletal muscle degeneration and heart failure, aiming to enhance life quality and longevity for …See details»
Member of Board of Directors: Driving Excellence in Gene Therapy
Myosana Therapeutics, Inc. is leading the efforts in developing new gene therapies that will slow skeletal muscle degeneration and heart failure to improve the quality of life, increase longevity …See details»
Myosana Therapeutics, Inc. Raises Up To $1M from ... - Business Wire
Apr 22, 2020 · NEWPORT BEACH, Calif. & SEATTLE-- ( BUSINESS WIRE )-- Myosana Therapeutics, Inc., a new biotech company developing novel platform technology for non-viral …See details»
Myosana Therapeutics, Inc. - Overview, News & Similar ... - ZoomInfo
Aug 25, 2021 · View Myosana Therapeutics, Inc. (www.myosanatherapeutics.com) location in Arizona, United States , revenue, industry and description. Find related and similar companies …See details»
Leadership Team: Guiding Innovation in Gene Therapies
Myosana Therapeutics, Inc. is leading the efforts in developing new gene therapies that will slow skeletal muscle degeneration and heart failure to improve the quality of life, increase longevity …See details»
GLUT4 Transporter: Redefine Non-Viral Gene Therapy Excellence
Myosana is pioneering a targeted non-viral gene therapy platform for neuromuscular and cardiac genetic diseases. Our platform is designed to overcome the limitations of viral delivery, …See details»